#Telemedicine #Stocks
to Watch - (OTCPINK: $GTCH) (NYSE:
$TDOC) (NYSE: $HUM) (TSXV: $DOC.V) (NasdaqGS: $LVGO) @GbtTechnologies @TeladocHealth @Humana @Livongo @CloudMD_SS
#COVID19
and the Accelerating Rise of Telemedicine
Point Roberts WA, Delta BC, September 25,
2020 Investorideas.com,
a global news source and leading retail investor and trader resource issues a
sector snapshot looking at the growing telemedicine market and participating
public companies rising to meet the needs of innovation in healthcare,
including GBT Technologies Inc. (OTCPINK:GTCH).
Read
this news, featuring GTCH in full at https://www.investorideas.com/news/2020/biotech/09251Telemedicine-Stocks.asp
Telemedicine – the practice of providing or
distributing healthcare-related services and information remotely, through
digital and telecommunications technology means – is one of the fortunate
industries to have risen in significance during the COVID-19 pandemic. The
reasons for this are perhaps not difficult to guess. The prominence of social
distancing guidelines and more particularly, the widespread policy (or advocacy
for) quarantining has made traditional visits to clinics and hospitals more
difficult. And in the months since the COVID-19 outbreak, this has been
exacerbated at times by the delaying and postponing
of non-emergent care. Naturally, this has led to the benefits of telemedicine,
such as the ability to long-distant diagnose, inform, and monitor patients, making
it even more relevant during this pandemic.
This is not to give the impression however,
that telemedicine would not have become a consequential market regardless of a
crisis like COVID-19. According to a report published before COVID-19, from Fortune Business Insights,
the global market for telemedicine was valued at USD $34.28 billion in 2018,
and is projected to reach USD $185.66 billion by 2026, making for a compound
annual growth rate (CAGR) of 23.5 percent in the forecast period (2019-2026).
But similar to other markets, like digital retail, telemedicine was already
gaining traction and was well-positioned to meet the increasing demand brought
on by the virus.
Like many emerging industries, the telemedicine space is seeing the surfacing of a panoply of different solutions. This is exemplified by qTerm, an AI-powered human vitals device from GBT Technologies Inc. (OTCPINK:GTCH) and its Joint Venture GBT Tokenize Corp. According to a recent press release, the qTerm device “is targeted to measure body temperature, blood pressure, and heart rate – all with a simple touch of the finger.” The device is deliberately small, able to be “be easily attached to a smart phone,” and coupled with an app, stores “a history for the user's records and provide numerical and statistical data about the user's body temperature.” This is enhanced further, as the devices AI anonymously and securely collects the user data, constructing a global ‘thermal map’ to alert about potential health risks proximities.
"This is the key highlight of the
device," said Danny Rittman, CTO of GBT Technologies Inc. in a recent interview about qTerm. “Every
person is going to be put on the world map for the benefit of the
community."
In a recent interview with Capital
Market Laboratories (CMLviz), Livongo Health, Inc. (NasdaqGS:LVGO)
CEO, Zane M. Burke affirmed this, saying: “before the COVID, we had a ton of
momentum.” But Burke also explained that, with the pandemic, people caught on
to the advantages in the technology:
“…what
occurred here is really everybody recognized first, the value of tele-health.”
He continued:
“The
second part of this is remote patient monitoring became really meaningful, both
from a regulatory and reimbursement perspective, as well as sort of people
waking up to hey, the future of healthcare is going to be consumer directed
virtual care.”
More recently, Livongo and telemedicine
giant Teladoc Health, Inc. (NYSE:TDOC) filed a definitive proxy
statement and prospectus with the US Securities and Exchange Commission (SEC)
with regard to a proposed merger of the two firms. According to the press
release, the two companies plan to “provide a consumer centered virtual care platform
for the full spectrum of health needs, creating a new standard in global
healthcare delivery, access and an improved consumer experience.”
Another approach is that of healthcare and
well-being firm Humana Inc. (NYSE:HUM) which recently announced an expanded
relationship with tech-enabled health services company, Seniorlink, Inc. The
collaboration will see Humana leverage Seniorlink’s digital care collaboration
platform Vela, to support its vulnerable, high risk members by “increasing the
overall engagement and reducing barriers to contact between members and care
managers.” Tom Riley, President and CEO of Seniorlink, said:
"The
COVID-19 crisis has prompted the healthcare industry to re-imagine care
delivery for our country's most vulnerable. By leveraging Vela, more of
Humana's high-risk members will have access to their integrated care team in
one platform. This is particularly advantageous at a time when many members
want to access care from home."
In addition to the various approaches
employed to contend with COVID-19, the space has seen individual firms enjoy
massive growth in the wake of the pandemic. Software-as-a-service (SaaS) based
health technology solutions provider CloudMD Software & Services Inc. (TSXV:DOC) recently reported a year-over-year
total revenue increase from Q2 2019 to Q2 2020. Notably, the company saw “gross
margins of 42% due to higher margin verticals and increase in telehealth usage,”
according to the press release. The company’s CEO, Essam Hamza, in discussing
his own firm’s success amidst the pandemic, provided a microcosm of the wider
market:
“We
are currently in the worst public health crisis of our lifetime and as a front
line physician for over 20 years I acutely understand the toll it is taking on
our healthcare system and the importance of access to quality health care. Our
CloudMD platform is well equipped to increase access through the availability
of our seamless virtual care solutions that allow patients to access quality
health care from anywhere.”
Telemedicine’s utility extends beyond the
current pandemic, as demonstrated by the pre-COVID projections in the
aforementioned research published by Fortune Business Insights. In fact, an
article published by the International Journal of Health Policy and Management
(IJHPM), titled: Climate Change and
Telemedicine: A Prospective View,
argues that it can be beneficial in the context of climate crisis as well. This
is not only manifested in its application in treating climate change’s many
effects on public health as outlined by the CDC, but the IJHPM article
points out the reduction of unnecessary travel and its resulting emissions that
adopting telemedicine would achieve. An excerpt reads:
In
another study, conducted in Canada, a wide range of healthcare services were
provided in the form of teleconsultation and as a result road trips were
reduced by 757 234 km, and transport vehicle carbon dioxide emissions were
reduced by 185 tons.
Similar to the transformation in the retail
sector toward digital technology, the long-distance interactions that
telemedicine facilitates already showed tremendous promise, but the COVID-19
pandemic has accelerated its growth and seems to have assured its endurance.
For
a list of telemedicine stocks visit
here.
Investors
can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com -
News that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye Podcast
and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced
news, articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each company
directly regarding specific questions. Disclosure: GTCH is a paid monthly
featured company for news and social media on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.aspLearn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
BiotechIndustryStocks.com -
investing ideas in biotechnology stocks, medical technology and life sciences
Like Biotech Stocks? View
our Biotech Stocks
Directory
Get
News Alerts on Biotech Stocks
Buy a biotech
guest post on Investorideas.com
Get more tech stocks investor ideas- news, articles, podcasts and stock directories
